Shaheenah S. Dawood

Shaheenah S. Dawood

St Lukes Medical Center
Quezon City, Philippines

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Efficacy and safety of tarlatamab, a DLL3-targeted bispecific T-cell engager, in a patient with advanced esophageal small-cell neuroendocrine carcinoma: a case report.

Efficacy and safety of tarlatamab, a DLL3-targeted bispecific T-cell engager, in a patient with advanced esophageal small-cell neuroendocrine carcinoma: a case report.

Journal: Immunotherapy
Published: March 28, 2026

SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.

SERENA-6 interpretation and clinical implications: intercepting endocrine resistance in metastatic breast cancer.

Journal: NPJ breast cancer
Published: March 09, 2026

Implementing SERENA6 in the clinic in the UAE: critical thinking of a community oncologist.

Implementing SERENA6 in the clinic in the UAE: critical thinking of a community oncologist.

Journal: ESMO open
Published: September 09, 2025

Actionable genomic landscape of biliary tract cancer in the Indian population.

Actionable genomic landscape of biliary tract cancer in the Indian population.

Journal: The oncologist
Published: August 30, 2025

Real-World Genomic Landscape of Gastrointestinal Cancers in Asia and the Middle East Using Comprehensive Circulating Tumor DNA Next-Generation Sequencing.

Real-World Genomic Landscape of Gastrointestinal Cancers in Asia and the Middle East Using Comprehensive Circulating Tumor DNA Next-Generation Sequencing.

Journal: Oncology research and treatment
Published: August 06, 2024

Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus.

Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus.

Journal: Frontiers in oncology
Published: June 05, 2024

Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East.

Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East.

Journal: Frontiers in oncology
Published: May 02, 2024

Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice.

Genomic Landscape of Advanced Solid Tumors in Middle East and North Africa Using Circulating Tumor DNA in Routine Clinical Practice.

Journal: Oncology
Published: March 18, 2024

Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.

Discordance in Recommendation Between Next-Generation Sequencing Test Reports and Molecular Tumor Boards in India.

Journal: JCO global oncology
Published: March 14, 2024

Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies.

Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies.

Journal: Frontiers in oncology
Published: January 21, 2024

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 01, 2023

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Indirect Treatment Comparison of First-Line CDK4/6-Inhibitors in Post-Menopausal Patients with HR+/HER2- Metastatic Breast Cancer.

Journal: Cancers
Published: August 09, 2023
Showing 1-12 of 83

Last Updated: 09/26/2026